109 related articles for article (PubMed ID: 3053574)
21. Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
Reddy AK; Garg P; Alam MR; Gopinathan U; Sharma S; Krishnaiah S
Eye (Lond); 2010 Jan; 24(1):170-4. PubMed ID: 19229279
[TBL] [Abstract][Full Text] [Related]
22. In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
Fujimoto T; Mitsuhashi S
Chemotherapy; 1990; 36(4):268-76. PubMed ID: 2174762
[TBL] [Abstract][Full Text] [Related]
23. Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.
Howard BM; Pinney RJ; Smith JT
Microbios; 1993; 75(304):185-95. PubMed ID: 8246811
[TBL] [Abstract][Full Text] [Related]
24. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Howard BM; Pinney RJ; Smith JT
Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
Oliveira AD; D'Azevedo PA; Francisco W
Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
[TBL] [Abstract][Full Text] [Related]
26. The postantibiotic suppressive effect of L-ofloxacin, an optically active isomer of ofloxacin.
Fu KP; Foleno B; Rosenthale ME
Diagn Microbiol Infect Dis; 1992; 15(4):375-8. PubMed ID: 1611855
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of levofloxacin, ofloxacin and other quinolones against coagulase-negative staphylococci.
Foleno BD; Lafredo SC; Fu KP
Chemotherapy; 1993; 39(2):120-3. PubMed ID: 8458244
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of levofloxacin against gram-positive bacteria.
Montanari MP; Mingoia M; Marchetti F; Varaldo PE
Chemotherapy; 1999; 45(6):411-7. PubMed ID: 10567771
[TBL] [Abstract][Full Text] [Related]
29. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial activity of fluoroquinolones in combination with zidovudine.
Lewin CS; Allen RA; Amyes SG
J Med Microbiol; 1990 Oct; 33(2):127-31. PubMed ID: 2121991
[TBL] [Abstract][Full Text] [Related]
31. 4-Quinolone bactericidal mechanisms.
Howard BM; Pinney RJ; Smith JT
Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
[TBL] [Abstract][Full Text] [Related]
32. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
[TBL] [Abstract][Full Text] [Related]
33. Review of preclinical studies with ofloxacin.
Sanders CC
Clin Infect Dis; 1992 Feb; 14(2):526-38. PubMed ID: 1554842
[TBL] [Abstract][Full Text] [Related]
34. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase.
Lewin CS; Howard BM; Smith JT
J Med Microbiol; 1991 Jan; 34(1):19-22. PubMed ID: 1703579
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.
Madhusudhan KT; Counts C; Lody C; Carter O; Dodson S; Ojha N
Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053
[TBL] [Abstract][Full Text] [Related]
36. In-vitro selection of bacteria resistant to the 4-quinolone agents.
Limb DI; Dabbs DJ; Spencer RC
J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
[TBL] [Abstract][Full Text] [Related]
37. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
Lewin CS; Amyes SG
J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
[TBL] [Abstract][Full Text] [Related]
38. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
[TBL] [Abstract][Full Text] [Related]
39. 4-Quinolone interactions with gyrase subunit B inhibitors.
Lewin CS; Howard BM; Smith JT
J Med Microbiol; 1991 Dec; 35(6):358-62. PubMed ID: 1661337
[TBL] [Abstract][Full Text] [Related]
40. Effect of quinolones against slowly growing bacteria.
Dalhoff A; Matutat S; Ullmann U
Chemotherapy; 1995; 41(2):92-9. PubMed ID: 7758362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
